Viewing StudyNCT06161272



Ignite Creation Date: 2024-05-06 @ 7:52 PM
Last Modification Date: 2024-10-26 @ 3:15 PM
Study NCT ID: NCT06161272
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-12-07
First Post: 2023-11-30

Brief Title: Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi
Sponsor: Guangxi Medical University
Organization: Guangxi Medical University

Conditions & Keywords Data

Conditions:
Name
Fallopian Tube Cancer
Ovarian Cancer
High Grade Serous Adenocarcinoma of Ovary
Primary Peritoneal Carcinoma
Keywords:
Name View
Apatinib View
ovarian cancer View
PARP inhibitors View
Flzuoparib View
Antiangiogenic agents View